Elder Pharmaceuticals Ltd
Next 500 2015
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Next 500 India
#142(2015)
#142(2015)
Financial Data 2014
Revenue
1,296
(INR Cr)
Net Operating Income
1,009
(INR Cr)
Assets
1,642
(INR Cr)
Profit
-7
(INR Cr)
Net Worth
773
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1296 -22.6% | 1676 22.7% | 1366 29.3% | 1056 35.1% | 782 20.0% | 652 - |
| Net Operating Income (INR Cr) | 1009 -38.54% | 1642 22.99% | 1335 38.28% | 965 33.77% | 722 16.32% | 620 12.54% |
| Profit (INR Cr) | -7 - | 82 14.0% | 72 12.5% | 64 29.7% | 50 -18.6% | 61 - |
| Assets (INR Cr) | 1642 -22.9% | 2129 18.6% | 1795 21.3% | 1480 39.0% | 1065 19.5% | 891 - |
| Net Worth (INR Cr) | 773 0.5% | 769 9.8% | 701 11.1% | 631 31.3% | 480 22.5% | 392 7.6% |
| Employee Cost (INR Cr) | 218 -6.5% | 233 29.6% | 180 51.1% | 119 23.2% | 97 15.3% | 84 - |
| Interest Cost (INR Cr) | 276 | 155 | 102 | 66 | 53 | 41 |
| Cash & Bank Balance (INR Cr) | 547 | 103 | 154 | 267 | 79 | 146 |
| Total Debt (INR Cr) | 848 | 1344 | 1081 | 832 | 574 | 499 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|
| Profit As % Of Revenues | - | 4.9% | 5.3% | 6.1% | 6.3% | 9.3% |
| Profit As % Of Assets | - | 3.9% | 4.0% | 4.3% | 4.7% | 6.8% |
| Profit As % Of Networth | - | 10.7% | 10.3% | 10.2% | 10.3% | 15.5% |
| Interest Cost to EBITDA % | - | 57.2% | 50.7% | 39.5% | 44.9% | 42.4% |
| Debt to Equity Ratio | 1.10 | 1.75 | 1.54 | 1.32 | 1.19 | 1.27 |
| RONW | - | 9.0% | 10.8% | 11.3% | 10.7% | 12.4% |
| ROCE | -3.5% | 10.6% | 11.8% | 11.5% | 11.2% | 12.0% |